About
ClearB Therapeutics is developing a therapeutic vaccine aimed at redirecting the immune system to achieve a functional cure for chronic hepatitis B by delivering antigenic epitopes correlated with viral clearance in elite responders.
Explore ClearB Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.